New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

Experts discuss the underutilization of biomarker testing in metastatic lung cancer, emphasizing the need for improved ...

Source: Getty Images Despite proven benefits, biomarker tests remain underused in clinical practice. By examining genetic markers from urine or tissue samples, biomarkers provide a more precise ...

Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...

Biomarkers can shape a breast cancer treatment plan, Andy Guinigundo explained in an interview with CURE. “It definitely can change your treatment plan,” said Guinigundo. “With these estrogen ...

A panel held during the Institute for Value-Based Medicine event in Chicago on August 14, 2025, included discussions of access to biomarker testing and perioperative treatment in patients with ...

Cancer is often caused by genetic mutations, which can lead to abnormal cell growth in the body. One type is called the KRAS G12C mutation, which happens in the KRAS protein.[1] KRAS acts as the ...

Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...

Young lung cancer patients have a higher incidence of targetable biomarkers, necessitating comprehensive testing for ALK fusions and EGFR mutations. Repeat biomarker testing is essential when ...

KUTV — July is Sarcoma Awareness Month, a time to raise understanding about rare cancers like synovial sarcoma—a life-threatening soft tissue cancer that often appears as a painful lump near the knee, ...

Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting practices, labs, and biopharma for improved patient outcomes. PCC focuses on ...

After gaining momentum last session, cancer care advocates returned to Beacon Hill Tuesday to promote bills expanding access to biomarker testing, which can help oncology providers determine targeted ...